Sort
261,768 grants matching “gene therapy”
SC COBRE for Developmentally Based Cardiovascular Diseases
$1,097,689Roger R Markwald · Medical University Of South Carolina · P30 · FY2015 · GM
SC COBRE for Developmentally Based Cardiovascular Diseases
$1,097,689Roger R Markwald · Medical University Of South Carolina · P30 · FY2016 · GM
Specialized Center of Research in Scleroderma
$1,097,677University Of Texas Hlth Sci Ctr Houston · P50 · FY2005 · AR
Novel Targets for Vaccine Therapy
$1,097,667Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Specialized Center of Research in Scleroderma
$1,097,581University Of Texas Hlth Sci Ctr Houston · P50 · FY2004 · AR
MODELS OF HUMAN IMMUNODEFICIENCIES
$1,097,555Beth Israel Deaconess Medical Center · P01 · FY2000 · AI
Signal Transduction Events and the Regulation of Cell Growth
$1,097,545Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2020 · CA
GENE THERAPY FOR METABOLIC DISORDERS
$1,097,499University Of Minnesota Twin Cities · P01 · FY2002 · HD
Specialized Center of Research in Scleroderma
$1,097,493University Of Texas Hlth Sci Ctr Houston · P50 · FY2003 · AR
Epigenetic mechanisms regulating the Igf2/H19 and Kcnq1 locus
$1,097,475Karl Eric Pfeifer · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD
Computational Tools For Bioinformatics And Genome Analysis
$1,097,447John I Powell · Center For Information Technology · ZIA · FY2015 · CT
Signal Processing And Instrumentation Section
$1,097,447Thomas J Pohida · Center For Information Technology · ZIA · FY2015 · CT
Maintenance of Models of Human Hemophilia and VWD
$1,097,318Timothy Charles Nichols · Univ Of North Carolina Chapel Hill · R24 · FY2018 · HL
Novel AMPK activator for treatment of congenital X-linked nephrogenic diabetes insipidus in pediatric patients
$1,096,928Jeff M Sands · Nephrodi Therapeutics, Inc. · R44 · FY2025 · DK
TrkB.T1 as a Genetic Disease Modifier of Muscular Dystrophy
$1,096,812Susan G Dorsey · University Of Maryland Baltimore · RC2 · FY2010 · NR
?Resetting immune homeostasis: a non-invasive approach towards HIV eradication
$1,096,736Rafick-Pierre Sekaly · Case Western Reserve University · U01 · FY2019 · AI
Intrabiliary MR/RF-enhanced chemotherapy of malignant biliary obstructions
$1,096,715Xiaoming Yang · University Of Washington · R01 · FY2013 · EB
Histidine phosphorylation as a new target for cancer therapy
$1,096,680Tony R. Hunter · Salk Institute For Biological Studies · R35 · FY2024 · CA
Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies
$1,096,673Harry L Malech · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
$1,096,590Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
GENE THERAPY STRATEGIES FOR SICKLE CELL DISEASE
$1,096,463University Of California San Francisco · P01 · FY2004 · HL
Molecular Subtypes for Targeted Therapies in Alcoholic Hepatitis
$1,096,295Ramon Bataller · Univ Of North Carolina Chapel Hill · U01 · FY2014 · AA
ORAL MANIFESTATIONS OF AIDS
$1,096,127University Of California San Francisco · P01 · FY2002 · DE
Structure and function of eukaryotic DNA transposases
$1,096,040Frederick Dyda · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Rehabilitation Medicine Scientist Training (RMST) Program
$1,096,035Michael L Boninger · University Of Pittsburgh At Pittsburgh · K12 · FY2012 · HD